ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity

MOLECULAR THERAPY NUCLEIC ACIDS · Published 2026-07-01 · DOI 10.1016/j.omtn.2026.103001

Free full text

Authors (15)

Francesco De Chiara, Eva Coll-de la Rubia, Petra de Bruijn, Galja Pletikapić, Nicole Cnubben, Lianne Stevens, Emy Theunissen, Janne J. Turunen, Anita M. van den Hoek, Hans M.G. Princen, Wouter Beumer, Seda Yilmaz-Elis, Bart Klein, Sjef J. De Kimpe, Gerard Platenburg

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chiara, F., Rubia, E., Bruijn, P., et al. (2026). ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity. MOLECULAR THERAPY NUCLEIC ACIDS. https://doi.org/10.1016/j.omtn.2026.103001

Related articles

• Decoding preeclampsia: A fusion of multi-view machine learning and multi-omics to identify putative inflammation-related mechanisms · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Y-RNAs and their fragments reflect kidney injury in diabetic kidney disease · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Quieting the carrier: Matching delivery to immunology in anti-inflammatory mRNA therapy · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Polyamines are i-Motif disruptors · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Codon-Optimized Npc1 mRNA corrects Niemann-Pick type C1 disease phenotypes in vitro and in vivo · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Intranasal Tat-modified PEG-PCL nanomicelles delivering anti-RelA siRNA attenuate ischemia-reperfusion injury in transient MCAO mice · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Antisense Peptide Nucleic Acids Targeting Ribosomal Protein Genes: A Novel Strategy Against Carbapenem-resistant Acinetobacter baumannii · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• To scramble or not: steric blocking 2′-MOE/PS control antisense oligonucleotides across cellular models · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Evaluation of lipid nanoparticle adjuvants with different PEG lipid ratios and phospholipid modifications in non-human primates · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal